EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Advancing Biopharmaceutical Innovation Through Cell Encapsulation and Biomimetic Therapeutic Systems
My interest in biopharmaceutical engineering began during my senior year as an undergraduate For my capstone project I worked on the encapsulation of...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
FDA Drug Approval Pathways: Strategies for U.S. Pharmaceutical Companies
Getting a new medicine from the lab bench to a patients medicine cabinet is one of the longest costliest and most heavily scrutinized journeys in American business For every drug that reaches pharmacy shelves thousands of molecules never make it out of early testing The difference between the ones that succeed and the ones that stall often isnt the science alone its the regulatory strategy behind...
-
Techno Trends
FDA Authorises Aletta for Autonomous Blood Collection
The US Food and Drug Administration FDA has authorised Aletta the first standalone robotic device designed to collect blood from a patients arm without handson operator intervention
-
Projects
Cambrex Expands Milan R&D Operations With US$30 Million Investment
Cambrex has begun construction of a new research and development facility at its Profarmico Milano site in Italy supported by a US million investment The initiative is designed
-
Research Insights
Phycocyanobilin: A potential bioactive compound from Arthrospira platensis targeting LYN protein associated with systemic lupus erythematosus
Phycocyanobilin a bioactive compound derived from Arthrospira platensis C was investigated for its potential role in systemic lupus erythematosus SLE based on its structural similarity to bilirubin
-
White Papers
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys complexity
TOP ARTICLES
-
1
Unlocking the Power of Biomarkers: A Comprehensive Guide
Kate Williamson
Biomarkers, spanning genes, proteins, and imaging features, are pivotal in healthcare, offering insights into disease, personalized treatment, and drug development. Challenges include standardization...
-
2
Continuous Manufacturing: The New Standard for Agile Pharma Production
Lakshmi
Continuous manufacturing has moved from demonstration to expectation. This article examines what it changes in the control strategy rather than merely the equipment, the economics American executives...
-
3
New Drug Development and Clinical Trial Design by Applying Genomic Information Management
Jeong-An Gim
Young Kyung Ko
Depending on the patients’ genotype, the same drug may have different efficacies or side effects. With the cost of genomic analysis decreasing and reliability of analysis methods improving, vast...
-
4
Revolutionizing Drug Design for a Brighter Future: Harnessing the Power of Artificial Intelligence and Machine Learning
Vidya Niranjan
In this editorial, we explore the remarkable potential of artificial intelligence (AI) and machine learning (ML) in revolutionizing the field of drug design. Traditional drug discovery pipelines have...
-
5
Next-Generation RNA Therapeutics: Expanding the R&D Landscape Beyond Vaccines
Lakshmi
mRNA vaccines proved the chemistry; they did not define the category. Silencing, splicing, editing and in-vivo cell engineering have turned RNA into a mainstream pharmaceutical modality, with roughly...
press releasesRead more...
OncoC4 Receives FDA Fast Track Designation for Cesalatamig, an Investigational PD-1/VEGF Bispecific Antibody
OncoC Inc a late clinicalstage biopharmaceutical company developing novel medicines for cancer and neurodegenerative diseases today announced that the US FDA has granted Fast Track Designation
Mission Bio Launches Tapestri® Triomics for Simultaneous DNA, RNA, and Protein Analysis at Single-Cell Resolution
Mission Bio a leader in singlecell multiomics today announced Tapestri Triomics a new expansion of the Tapestri Platform that simultaneously analyzes DNA RNA and protein in the same cell By connecting genotype
Jazz Pharmaceuticals Completes Acquisition of Actio Biosciences
Jazz Pharmaceuticals plc Nasdaq JAZZ Jazz or the Company today announced the successful completion of its acquisition of privatelyheld Actio Biosciences Inc Actio for million upfront Actio
Asahi Kasei Introduces VANTIJ® SU-VFC Benchtop to Improve Efficiency and Consistency in Gene Therapy Manufacturing
Asahi Kasei Bioprocess a subsidiary of diversified global company Asahi Kasei will unveil the VANTIJ SUVFC Benchtop at Bioprocess International East BPI EAST This new VANTIJ SUVFC is a smallformat system
Events Read more...
15 - 17
Sep 2026COPD Drug Development Summit 2026
Street, Boston, MA 02210, USA
21 - 23
Sep 2026Cell & Gene Therapy World Conference
Miami, Florida, USA
21 - 23
Sep 2026Cancer R&D World Conference
Hilton Garden Inn Miami Dolphi...
22 - 23
Sep 2026PDA Advanced Parenteral Therapeutics & Quality
Illume Hotel Taipei, Taiwan
22 - 24
Sep 2026InsurInnovator Connect Asia
Singapore
28 - 02
Sep 2026Discovery on Target 2026
Boston, MA, USA
29 - 01
Sep 202610th IPF Summit 2026
Boston, MA, USA
29 - 01
Sep 2026Powtech Technopharm 2026
Nuremberg, Germany
LATEST NEWSRead more...
ProBio and Kun Tuo collaborate on integrated CDMO-CRO solutions for advanced therapies
ProBio has entered into a strategic collaboration with Kun Tuo an IQVIA company and clinical research organisation CRO in China to support biopharmaceutical companies developing advanced therapies in the Chinese market
DifGen Pharmaceuticals receives FDA approval for epinephrine injection
DifGen Pharmaceuticals has received approval from the US Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA for Epinephrine Injection USP mgmL in singledose vials
VaxThera and Codagenix partner to advance next-generation yellow fever vaccine
VaxThera SAS a Colombian biotechnology company developing and manufacturing vaccines and biological products has entered into an agreement with Codagenix Inc to exclusively license
BostonGene expands collaboration with Dana-Farber to advance breast cancer research
BostonGene has expanded its scientific collaboration with DanaFarber Cancer Institute to study the biological mechanisms involved in BRCA and BRCAassociated breast cancers
Curium Receives FDA Approval for BEXLUTRY Radioligand Therapy for GEP-NETs
Curium has received approval from the US Food and Drug Administration FDA for BEXLUTRY lutetium Lu dotatate injection to treat adults with somatostatin receptorpositive gastroenteropancreatic neuroendocrine tumours GEPNETs
Aptar Pharma and Massachusetts General Hospital Partner on Nose-to-Brain Drug Delivery Research
Aptar Pharma and Massachusetts General Hospital MGH have entered into a research collaboration to advance nosetobrain NB drug delivery for neurological and central nervous system CNS diseases
